All terms in GECCO

Label Id Description
toxoplasmosis toxoplasmosis
Dietary_Supplements Dietary_Supplements
right_ventricular_end-systolic_volume right_ventricular_end-systolic_volume
Antiviral_Therapy Antiviral_Therapy
Milliequivalent_per_Liter Milliequivalent_per_Liter
IgG2_immunoglobulin_complex_(human) IgG2_immunoglobulin_complex_(human)
If_mechanical_ventilation_please_state_the_mean_fraction_of_inspired_oxygen_(FIO2) If_mechanical_ventilation_please_state_the_mean_fraction_of_inspired_oxygen_(FIO2)
blood_sodium_level blood_sodium_level
record_identifier record_identifier
SARS-CoV-2 (COVID-19) IgG IA Ql GECCO_2.16.840.1.113883.3.1937.777.53.2.2.2248 [SARS-CoV-2 antibodies]
SARS-CoV-2-RT-PCR GECCO_2.16.840.1.113883.3.1937.777.53.2.2.2247 [SARS-CoV-2-RT-PCR, SARS-COV-2-RT-PCR]
Escherichia_coli_[E._coli_]_as_the_cause_of_diseases_classified_elsewhere Escherichia_coli_[E._coli_]_as_the_cause_of_diseases_classified_elsewhere
Interleukin 6 GECCO_2.16.840.1.113883.3.1937.777.53.2.2.2244 [Interleukin 6]
Zinc 764877006
Voclosporin L04AD03
T2_relaxation_time_(medial_ventricular_septum) T2_relaxation_time_(medial_ventricular_septum)
hepatitis_C hepatitis_C
Paracetamol Kombinationen mit Coffein N02BE61
Base_excess:SCnc:Pt:BldA:Qn:Calculated Base_excess:SCnc:Pt:BldA:Qn:Calculated
Angiotensin_II_Type_1_Receptor_Blockers Angiotensin_II_Type_1_Receptor_Blockers